Clinical Trial Update: A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA) [Phase 4]

View source ↗

Summary

Phase 4 multicenter trial evaluating the contrast agent Iomeron-400 used with MDCTA has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Disease
• Carotid Artery Disease
• Peripheral Artery Disease
• Pulmonary Disease

Drugs mentioned

• Iomeron-400 (iopromide)

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Aortic Disorders, Carotid Disease | Phase 4 | Status: COMPLETED